Clinical trial

Immune Response to Immunotherapy in Lung Cancer: Study of Sputum and Blood Samples

NCT07163507

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Study at a glance

Registry-backed

Immune Response to Immunotherapy in Lung Cancer: Study of Sputum and Blood Samples

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov
StatusNOT_YET_RECRUITING
Study typeINTERVENTIONAL
Start date2026-04-01
PhaseNA
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.